Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1LGM Pharma
03 1Moehs Iberica
04 1Ami Lifesciences Private Limited
05 1Omgene Life Sciences Pvt. Ltd
06 2Alembic Pharmaceuticals Limited
07 1Aurisco Pharmaceutical
08 1Bacto Chem
09 1Beijing Mesochem Technology
10 1BrightGene Bio-Medical Technology Co.,Ltd
11 1CHEMO
12 1Changzhou Pharmaceutical Factory
13 1Chromo Laboratories
14 1Eagle Chemical
15 1Guangzhou Tosun Pharmaceutical
16 1Hetero Drugs
17 1Industriale Chimica
18 1Kaifeng Pharmaceutical Group Co., Ltd
19 1Kimia Biosciences
20 1MSN Laboratories
21 1Mankind Pharma
22 1Optimus Pharma
23 1Sichuan Renan Pharmaceutical
24 1Sichuan Xieli Pharmaceutical
25 1Solara Active Pharma Sciences
26 1Valence Labs
27 1Viruj Pharmaceuticals Pvt Ltd
28 1Waterstone Pharmaceuticals Inc.
29 1Yonsung Fine Chemicals
01 9China
02 16India
03 1Italy
04 1South Korea
05 2Spain
06 1U.S.A
01 11Active
02 19Blank
01 30Blank
01 30Blank
01 1WC-0054
02 1WC-0082
03 1WC-0082A11
04 1WC-0383A8
05 1WC-0474A3
06 1WC-0511
07 24Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-02-10
Pay. Date : 2019-12-30
DMF Number : 34413
Submission : 2019-12-27
Status : Active
Type : II
Date of Issue : 2021-10-22
Valid Till : 2024-10-21
Written Confirmation Number : WC-0511
Address of the Firm :
NDC Package Code : 73435-004
Start Marketing Date : 2019-12-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38221
Submission : 2023-03-27
Status : Active
Type : II
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm :
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-08-01
Pay. Date : 2019-07-08
DMF Number : 33610
Submission : 2019-02-28
Status : Active
Type : II
Date of Issue : 2021-02-12
Valid Till : 2022-08-08
Written Confirmation Number : WC-0383A8
Address of the Firm :
NDC Package Code : 69766-066
Start Marketing Date : 2019-02-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-26
Pay. Date : 2019-11-06
DMF Number : 33960
Submission : 2019-11-07
Status : Active
Type : II
NDC Package Code : 59285-028
Start Marketing Date : 2019-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34561
Submission : 2020-02-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38348
Submission : 2023-05-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-31
Pay. Date : 2021-09-16
DMF Number : 36292
Submission : 2021-09-29
Status : Active
Type : II
We have 29 companies offering Obeticholic Acid
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?